SakuraBead Resorbable Microspheres for osteoarthritis, knee

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 12 Aug 2024: Trial registered, NCT06550024
  2. 5 Dec 2024: Trial registered, NCT06718478

The trials

NCT06550024: SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization

State
Under way
Phase
No phase
People
89 planned
Started
28 Nov 2024
Primary completion
Dec 2026
Arms
Genicular Artery Embolization (GAE)
Results
None posted
  1. 12 Aug 2024: Trial registered
  2. 28 Nov 2024: Trial started

NCT06718478: First in Human Study of SakuraBead for Genicular Artery Embolization to Treat Pain Secondary to Knee Osteoarthritis

State
Completed
Phase
No phase
People
15 taking part
Started
5 Dec 2023
Primary completion
28 Mar 2024
Arms
Genicular Artery Embolization (GAE)
Results
None posted
  1. 5 Dec 2023: Trial started
  2. 23 Aug 2024: Trial completed
  3. 5 Dec 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.